Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study About the Validity of MRS-guided Resection on Prognosis High-grade Gliomas

NCT02795364 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT02795364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02795364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study About the Validity of MRS-guided Resection on Prognosis High-grade Gliomas
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2016
Completion date
May 31, 2018
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anaplastic oligoastrocytoma, glioblastomas (gbm), glioma